Loading...

THROMBOPHILIA PROFILE SUPER MAXI

image not found

 NABL Cap Accredited 
The Thrombophilia Profile Super Maxi is an extensive panel designed to evaluate genetic, biochemical, and coagulation factors that increase the risk of abnormal blood clotting. Metropolis Healthcare uses advanced molecular and hematological assays to detect inherited and acquired thrombophilia markers with high precision. This profile helps assess clotting tendencies in patients with recurrent thrombosis, unexplained pregnancy loss, or family history of clotting disorders. With comprehensive testing and expert reporting, Metropolis Healthcare provides valuable insights for targeted clinical management

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 22,000.00

Sample Type: Blood Culture Aerobic Bactec Bottle , EDTA Blood , Serum

Fasting Not Required


Notes:T0507

Frequently Asked Questions (FAQ's):

What does the Thrombophilia Profile Super Maxi include?
Metropolis Healthcare assesses genetic mutations, coagulation factors, protein deficiencies, and autoimmune markers linked to clotting disorders.

Why is this profile important?
This panel at Metropolis Healthcare helps identify the underlying cause of recurrent clots, miscarriages, or unexplained thrombotic events.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced PCR, immunoassays, and coagulation studies to deliver highly accurate thrombophilia results.

Who should take this test?
Individuals with a personal or family history of thrombosis, repeated pregnancy loss, or physician-recommended screening can benefit from this profile at Metropolis Healthcare.

What samples are required for this profile?
Blood samples are collected at Metropolis Healthcare to analyze genetic and coagulation markers comprehensively.

How long does it take to receive the results?
Due to its detailed components, Metropolis Healthcare provides results within a structured and reliable turnaround time.

Can this test help identify inherited clotting disorders?
Yes, Metropolis Healthcare evaluates key genetic mutations and protein deficiencies to detect inherited thrombophilia.

 

Does Metropolis Healthcare offer interpretation support?
Metropolis Healthcare provides expert-reviewed reports to help clinicians understand the findings and plan appropriate treatment or preventive strategies

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab